TTX-080

Product Description: TTX-080 is a humanized monoclonal antagonistic antibody targeting human leukocyte antigen G (HLA-G). TTX-080 exerts anti-tumor activity by relieving HLA-G-mediated immune suppression. TTX-080 is promising for research of solid tumors such as metastatic colorectal cancer (mCRC) and head and neck squamous cell carcinoma (mHNSCC)[1].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Ulahannan S V, et al. Results from phase 1a/1b analyses of TTX-080, a first in class HLA-G antagonist, in combination with cetuximab in patients (pts) with metastatic colorectal cancer and head and neck squamous cell carcinoma[J]. 2024.

Molecular Weight: N/A

Research Area: Cancer

Target: Others

• Artikelnummer: MEXHY-P991248-0
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P991248-0
• Verpackungseinheit: Get quote
• Mengeneinheit: STK
• Konjugat: Unconjugated